⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 6, 2005European Journal Of Haematology

Developing new drugs for the treatment of lymphoma

View Full Paper

Ask AI

Bookmark

Share

Authors

OOOwen A. O’ConnorVirginia Cancer Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Owen A. O’Connor (2005) studied this question.

synapsesocial.com/papers/6a0feba4d13714ec96fed1b1 https://doi.org/10.1111/j.1600-0609.2005.00470.x

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Characterization of the heat-stable polypeptide of the ATP-dependent proteolytic system from reticulocytes.1980 · 249 citations
2ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation.1980 · 562 citations
3Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma1993 · 2,166 citations
4Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma1996 · 24 citations
5Role of the proteasome and NF-κB in streptococcal cell wall-induced polyarthritis1998 · 287 citations